FATE
Fate Therapeutic (FATE)
NASDAQ
$2.11+$0.04 (+1.93%)
Price as of Oct 22, 2026 7:34 PM EDT
  • $248.0M
    Market Cap
  • 38.93%
    1-Year Change
  • Biotechnology
    Industry
FATE
vs History
vs S&P 500
General Statistics
Latest Close
$2.07
Change
+$0.010 (+0.49%)
Open
$2.06
High
$2.14
Low
$2.04
Previous Close
$2.06
Volume
1,215,151
30-Day Average Volume
1,375,742
1-Week Change
6.70%
1-Month Change
-18.18%
1-Year Change
38.93%
3-Year Change
3.50%
5-Year Change
-96.52%
Fundamentals
Shares Outstanding
119.8M
Total Assets
$260.1M
Market Cap
$248.0M
Enterprise Value
$215.6M
Period:
QTR
TTM
FY
Revenue
$2.1M
Net Income
-$30.2M
Free Cash Flow
-$23.5M
EBIT
-$30.2M
EBITDA
-$27.4M
Net Working Capital
$125.4M
EPS
-$0.25
Enterprise Value/EBITDA
-8
Enterprise Value/Revenue
104
P/B
2
P/E
-8
PEG
-2
Price/Free Cash Flow
-11
Price/Operating Cash Flow
-11
Dividends & Splits
Forward Annual Dividend Yield
N/A
Trailing Annual Dividend Yield
N/A
Ex-Dividend Date
N/A
Last Split Factor
N/A
Last Split Date
N/A

Earnings & Revenue